MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net of...
$7,728,423
Proceeds from exercised
warrants
$1,098,192
Net cash provided by
financing activities
$7,832,195
Canceled cashflow
$994,420
Net increase in cash
and cash...
$1,268,202
Canceled cashflow
$6,563,993
Deferred offering costs
paid
$712,669
Principal payments on
notes payable
$281,751
Accrued expenses
$1,082,727
Stock based
compensation
$596,852
Prepaids and other
current assets
-$240,975
Depreciation and
amortization
$59,501
Accounts receivable
-$46,589
Financing charges
$30,240
Provision for losses on
inventory
$30,070
Non-cash lease expense
$23,092
Loss on disposal of
property and equipment
-$7,878
Change in fair value of
warrant liability
$7,634
Provisions for losses on
accounts receivable
$2,326
Other income
$141,196
Net cash used by
operating activities
-$6,432,843
Net cash used by
investing activities
-$131,150
Canceled cashflow
$2,127,884
Total other income
(expense), net
$29,353
Net sales
$3,569,282
Canceled cashflow
$111,843
Net loss
-$7,800,555
Additions to intangible
assets
$100,000
Additions to property and
equipment
$31,150
Canceled cashflow
$29,353
Accounts payable
-$457,583
Inventory
$242,874
Operating lease liability
-$50,935
Other non-current
liabilities
-$4,913
Customer deposits
-$3,867
Gross profit
$3,006,366
Canceled cashflow
$562,916
Interest expense
$73,969
Financing charges
$30,240
Change in fair value of
warrant liability
$7,634
Operating loss
-$7,829,908
Canceled cashflow
$3,006,366
Cost of goods sold
$562,916
Wages and benefits
$4,550,833
Selling expenses
$2,279,974
Other operating
expenses
$1,525,419
Professional services
$1,296,368
Legal settlement
$630,568
Research and development
$493,611
Depreciation
$37,691
Amortization
$21,810
Back
Back
Cash Flow
source: myfinsight.com
Neuraxis, INC (NRXS)
Neuraxis, INC (NRXS)